Upvote
Downvote
Research Associate I / II, CRISPR Delivery Engineering
Share Job
- Suggest Revision
- Scribe Therapeutics is a molecular engineering company focused on creating best-in-class in vivo therapies that permanently treat the underlying cause of disease.
- Founded by CRISPR inventors and leading molecular engineers Benjamin Oakes, Brett Staahl, David Savage, and Jennifer Doudna, Scribe is overcoming the limitations of current genome editing technologies by developing custom engineered enzymes and delivery modalities as part of a proprietary, evergreen CRISPR by Design platform for CRISPR-based genetic medicine.
- We are seeking a highly creative, passionate, and motivated individual to join us in our quest to develop the next generation of CRISPR-based therapeutics.
- The current role is for a Research Associate I/II, CRISPR Delivery Engineering to join our team and advance our platform, designing and building new systems to deliver CRISPR in vivo.
- The candidate should have a passion for working collaboratively with biologists and bioengineers to enable building the necessary tools for meeting the new frontier of CRISPR-based therapeutics.
Active Job
Updated TodaySimilar Job
Relevance
Active